What is the recommended frequency and duration for Toradol (ketorolac) injections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safe Administration Frequency of Toradol (Ketorolac) Injections

Toradol (ketorolac) injections should not be used for more than 5 consecutive days due to significant risks of renal, gastrointestinal, and bleeding complications. 1, 2

Dosing Guidelines

Standard Dosing

  • Maximum duration: 5 days (absolute maximum) 1, 3
  • Intramuscular dosing:
    • Patients <65 years: 60 mg single dose or 30 mg every 6 hours
    • Patients ≥65 years, renally impaired, or <50 kg: 30 mg single dose or 15 mg every 6 hours
  • Intravenous dosing:
    • Patients <65 years: 30 mg single dose or 30 mg every 6 hours
    • Patients ≥65 years, renally impaired, or <50 kg: 15 mg single dose or 15 mg every 6 hours
  • Maximum daily dose:
    • Patients <65 years: 120 mg
    • Patients ≥65 years, renally impaired, or <50 kg: 60 mg 1

Important Safety Considerations

Contraindications

  • History of gastrointestinal bleeding or ulceration
  • Renal impairment or risk of renal failure
  • Compromised hemostasis or bleeding disorders
  • Hypersensitivity to aspirin or other NSAIDs
  • Pregnancy, labor, delivery, and nursing 4
  • Cerebrovascular hemorrhage 2

High-Risk Populations

  1. Elderly patients (≥65 years)

    • Require lower doses due to increased risk of adverse effects
    • Higher risk of GI bleeding and renal impairment 4
  2. Patients with renal impairment

    • Ketorolac is primarily excreted through the kidneys
    • Elimination half-life increases with renal impairment 5, 6
  3. Patients on anticoagulants

    • Increased risk of bleeding complications due to platelet inhibition 4
  4. Patients with history of GI issues

    • Higher risk of GI bleeding, ulceration, and perforation 4

Monitoring Requirements

For patients receiving ketorolac, especially those at higher risk:

  • Monitor blood pressure, BUN, creatinine, and liver function tests at baseline
  • Continue monitoring every 3 months for long-term users (though long-term use is not recommended) 6
  • Discontinue immediately if:
    • BUN or creatinine doubles
    • Hypertension develops or worsens
    • Signs of GI bleeding occur 6

Alternative Pain Management Options

When ketorolac is contraindicated or the 5-day maximum has been reached:

  • For mild to moderate pain: Acetaminophen or other oral NSAIDs with appropriate precautions
  • For moderate to severe pain: Transition to appropriate opioid analgesics 6
  • For patients with renal impairment: Consider methadone as it has primarily fecal excretion rather than renal elimination 6

Key Takeaways

  1. Ketorolac is a potent NSAID with significant analgesic properties but carries substantial risks
  2. The 5-day maximum duration is an absolute limit that should never be exceeded
  3. Patients should be transitioned to alternative analgesics as soon as possible
  4. The lowest effective dose should always be used
  5. Careful patient selection is essential to minimize adverse effects

Remember that while ketorolac is effective for short-term pain management, its use must be strictly limited due to its potential for serious adverse effects, particularly with prolonged use beyond the 5-day maximum.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ketorolac: a parenteral nonsteroidal antiinflammatory drug.

DICP : the annals of pharmacotherapy, 1990

Guideline

Ketorolac Use in Patients with Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.